Eden Health Clubs serves Greenwood Village, the Denver Tech Center (DTC), Cherry Hills Village, Centennial, Englewood, Littleton, and the broader south Denver metro. Tesamorelin is available through Eden’s Greenwood Village health club or via telehealth for established Eden patients in Colorado.
Quick answer
Tesamorelin at Eden Health Clubs is a clinician-guided protocol in Greenwood Village for adults exploring peptide therapy with an FDA-approved indication related to visceral fat, IGF-1, and body composition. Eligibility is determined during consultation with Eden’s clinical team and medical director oversight.
Visceral-fat peptide therapy
Visceral fat, the deep organ-wrapping kind, is not the same as the layer you can pinch. It is metabolically active, harder to lose, and often the kind that GLP-1 medications, training, and diet leave behind even when overall weight drops.
Tesamorelin is the protocol Eden considers when visceral fat is the specific conversation. It is a synthetic analog of growth-hormone-releasing hormone with an FDA-approved indication, originally for HIV-associated lipodystrophy.
Clinical interest today is broader, including body-composition support, IGF-1 elevation, and active-aging care. At Eden, the decision starts with consultation, labs when appropriate, and clinician review.
What it is
Tesamorelin is a synthetic GHRH analog that supports the body’s own growth-hormone signaling through the anterior pituitary. It is FDA-approved under the brand name Egrifta for HIV-associated lipodystrophy.
At Eden, Tesamorelin is prescribed only after clinical consultation, compounded in the U.S. when appropriate, and monitored with labs and follow-up so the protocol fits your goals and risk profile.
Who it is for
Eligibility for Tesamorelin is determined during clinical consultation.
Inside Tesamorelin
FDA-Approved GHRH Analog
A synthetic GHRH analog. FDA-approved as Egrifta for HIV-associated lipodystrophy. Studied for its role in reducing visceral fat, elevating IGF-1, supporting body composition, and supporting cognitive clarity in older adults.
Why Tesamorelin matters. Tesamorelin has a clearer regulatory story than many wellness peptides because it carries an FDA-approved indication. That does not make it right for every client, but it does make it an important option when the visceral-fat or IGF-1 conversation is the right one.
How it works at Eden
Why Eden
Pricing
Your consultation helps determine whether this protocol is appropriate and what level of support makes sense for your goals. Tesamorelin is personalized care, not a product on a shelf. Pricing is reviewed during your consultation so you leave with a clear plan and a clear number.
Why it matters
The kind of fat Tesamorelin is studied for is metabolically active, hormonally tangled, and different from ordinary weight-loss frustration.
The clients who shift it are usually the ones who get specific about the mechanism instead of trying harder at a general approach.
Consult availability with Eden’s clinical team is limited each week, and personalized protocols require clinical review.
FAQ
Tesamorelin is a synthetic GHRH analog that supports the body's own growth-hormone signaling and carries an FDA-approved indication for HIV-associated lipodystrophy.
Yes. Tesamorelin is FDA-approved under the brand name Egrifta for HIV-associated lipodystrophy. Eden still determines eligibility through consultation and clinical review.
No. Tesamorelin has a different mechanism than GLP-1 medications. For some clients, the conversations are complementary, especially when visceral fat remains a concern.
Often, yes, but Eden reviews your full medication list, labs, goals, and prescribing history before recommending whether it belongs in your plan.
Visceral-fat and body-composition changes usually require a longer timeline. IGF-1 changes may be seen earlier on labs. Individual response varies.
Long-term fit depends on your history, labs, risk factors, and response. Eden monitors eligibility and follow-up rather than treating Tesamorelin like an off-the-shelf product.
Your clinician may request IGF-1, metabolic markers, and other labs based on your history. Body-composition imaging may be considered when visceral fat is the lead concern.
Through clinical consultation, medical history, medication review, and labs when appropriate.
Many Eden protocols are paid out of pocket. Pricing and fulfillment details are reviewed during your consultation.
If you are a fit, your clinician designs the protocol, reviews fulfillment, and sets follow-up expectations before you start.
Start with a consultation
Eden will review your body-composition goals, GLP-1 history if relevant, medications, health history, IGF-1, metabolic markers, and whether Tesamorelin is clinically appropriate.
Greenwood Village health club consults and telehealth follow-ups may be available for established Colorado patients.
Information on this page is educational and is not a substitute for personalized medical advice. Eligibility for Tesamorelin is determined during clinical consultation. Results vary by individual. Tesamorelin has an FDA-approved indication, but not every use, client goal, or compounded form is FDA-approved. Eden Health Clubs makes no claims to diagnose, treat, cure, or prevent any disease.